Management Issues In Hematopoietic Stem Cell Transplantation

Seminars in Oncology Nursing

Volumn 25, Issue 2, 2009, Pages 151-158

  Rice, Robert David ^a   Bailey, Gay ^a  

^a NONE

Author keywords

administration; care delivery; Leadership; management

Indexed keywords

AMBULATORY CARE; ARTICLE; CASE MANAGEMENT; HEALTH CARE QUALITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEADERSHIP; NURSE ADMINISTRATOR; NURSE ATTITUDE; NURSING; NURSING ASSESSMENT; ONCOLOGY NURSING; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PROFESSIONAL PRACTICE;

AMBULATORY CARE; CASE MANAGEMENT; CONTINUITY OF PATIENT CARE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEADERSHIP; NURSE ADMINISTRATORS; NURSE'S ROLE; NURSING ASSESSMENT; ONCOLOGIC NURSING; PATIENT CARE TEAM; PROFESSIONAL AUTONOMY; QUALITY ASSURANCE, HEALTH CARE; QUALITY INDICATORS, HEALTH CARE;

EID: 65349127024     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soncn.2009.03.009     Document Type: Article

References (30)

1. Pasquini M., Wang Z., and Schneider L. Report on state of the art in blood and marrow transplantation. IBMTR/ABMTR Newsletter 13 (2007) 5-9
2. Campbell L.R., and Foody M.C. Administrative issues of an inpatient BMT unit. In: Buchsel P.C., and Whedon M.B. (Eds). Bone marrow transplantation: administrative and clinical strategies (1995), Jones and Bartlett, Boston, MA 39-68
3. Bodey G.P., Buckley M., Sathe Y.S., et al. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64 (1966) 328-340
4. Sheretz R.J., Belani A., Kramer B.S., et al. Impact of air filtration on nosocomial aspergillus infections: unique risk of bone marrow transplant patients. Am J Med 83 (1987) 709-718
5. Siegel JD, Rhinehart E, Jackson M, et al, and the Healthcare Infection Control Practices Advisory Committee. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. June 2007. Available at: http://www.cdc.gov/ncidod/dhqp/index.html# (accessed Oct 5, 2008).
6. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Recommendation of the Centers for Disease Control, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 6 suppl (2000) 7-83
7. Welte K., Gabrilove J., Bronchud M.H., et al. Filgrastim (r-metHuG-CSF): the first 10 years. Blood 88 (1996) 1907-1929
8. Schmitz N., Linch D.C., Dreger P., et al. Randomized trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 347 (1996) 353-357
9. Svahn B.M., Bjurman B., Myrback K.E., et al. Is it safe to treat allogeneic stem cell transplant recipients at home during the pancytopenic phase? A pilot trial. Bone Marrow Transplant 26 (2000) 1057-1060
10. Gluck S., des Rochers C., Cano C., et al. High-dose chemotherapy followed by autologous blood cell transplantation: a safe and effective outpatient approach. Bone Marrow Transplant 20 (1997) 431-434
11. Herrmann R.P., Trent M., Cooney J., et al. Infections in patients managed at home during autologous stem cell transplantation for lymphoma and multiple myeloma. Bone Marrow Transplant 24 (1999) 1213-1217
12. Meisenberg B.R., Ferran K., Hollenbach K., et al. Reduced charges and costs associated with outpatient autologous stem cell transplantation. Bone Marrow Transplant 21 (1998) 927-932
13. Bredeson C., Perry G., Martens C., et al. Outpatient total body irradiation as a component of a comprehensive outpatient transplant program. Bone Marrow Transplant 29 (2002) 667-671
14. Frey P., Stinson T., Siston A., et al. Lack of caregivers limits use of outpatient hematopoietic stem cell transplant program. Bone Marrow Transplant 30 (2002) 741-748
15. Clifford K.N. peripheral stem cell transplantation in the community setting. In: Buchsel P.C., and Kapustay P.M. (Eds). Stem cell transplantation: a clinical textbook (2004), Oncology Nursing Society, Pittsburgh, PA 12.3-12.13
16. Kelley C.H., Rudder Randolph S., and Leum E. Home care of peripheral stem cell transplantation recipients. In: Buchsel P.C., and Kapustay P.M. (Eds). Stem cell transplantation: a clinical textbook (2004), Oncology Nursing Society, Pittsburgh, PA 13.3-13.16
17. Buchsel P.C., and Kapustay P.M. Models of ambulatory care for blood cell and bone marrow transplantation. Ed 2. In: Whedon M.B., and Wujcik D. (Eds). Blood and marrow stem cell transplantation (1997), Jones and Bartlett, Boston, MA 525-561
18. Buchsel P.C. Administrative issues of an ambulatory care setting. In: Buchsel P.C., and Whedon M.B. (Eds). Bone marrow transplantation: administrative and clinical strategies (1995), Jones and Bartlett, Boston, MA 19-38
19. Adams L.L., and Johns A.A. Clinical and administrative support for hematopoietic cell transplant programs. In: Blume K.G., Forman S.J., and Appelbaum F.R. (Eds). Thomas' hematopoietic cell transplantation. Ed 3 (2004), Blackwell Publishing, Malden, MA 463-468
20. Lanier W.L., and Rose S.H. The contemporary medical community: leadership, mentorship, and career choices. Mayo Clin Proc 83 (2008) 974-977
21. Aiken L.H., Clarke S.P., Sloane D.M., et al. Hospital nurse staffing and patient mortality, nurse burnout, and job dissatisfaction. JAMA 288 (2002) 1987-1993
22. Cho S.H., Hwang J.H., and Kim J. Nurse staffing and patient mortality in intensive care units. Nurs Res 57 (2008) 322-330
23. Article 139, New York State Nurse Practice Act. Available at: http://www.op.nysed.gov/article139.htm (accessed Oct 5, 2008).
24. Guidelines regarding utilization of licensed nurses (RNs and LPNs) and unlicensed assistive personnel (UAP) in the delivery of nursing care. Available at: http://www.nysna.org/images/pdfs/practice/scope/rn_uap_guidelines04.pdf. (accessed Oct 5, 2008).
25. Cooke L., Gemmill R., and Grant M. Advanced practice nurses core competencies: a framework for developing and testing an advanced practice nurse discharge intervention. Clin Nurs Spec 22 (2008) 218-224
26. American Federation of Clinical Oncologic Societies. Access to quality cancer care: consensus statement. J Clin Oncol 16 (1998) 1628-1630
27. US Food and Drug Administration. Current good tissue practice for human cells, tissues, and cellular and tissue-based product establishments; inspection and enforcement. Food and Drug Administration 21 CFR Parts 16, 1270 and 1271. Federal Register 69 226 (2004) 68612-68688
28. Adams J.J., Brodie C., and Wilkins L.A. Managed care and peripheral stem cell transplantation. In: Buchsel P.C., and Kapustay P.M. (Eds). Stem cell transplantation: a clinical textbook (2004), Oncology Nursing Society, Pittsburgh, PA 18.3-18.14
29. LeMaistre C.F., and Loberiza F.R. What is quality in a transplant program?. Biol Blood Marrow Transplant 11 (2005) 241-246
30. FACT-JACIE (Foundation for the Accreditation of Cellular Therapy and Joint Accreditation Committee of the International Society of Cellular Therapy and the European Group for Blood and Marrow Transplantation) International Standards for Cellular Therapy Product Collection, Processing and Administration. Ed 4. 2008. Available at: http://www.factwebsite.org/uploadedFiles/News/4th%20Ed.%20Standards%20for%20Web.pdf (accessed Oct 5, 2008).